SWAP70

There are 3 papers on SWAP70 in aging research: 1 trial and 2 observational studies in people. The newest story, Oct 23, 2026: “Two blood proteins linked to small-vessel stroke risk”.

Gene

3 papers study it1 finding

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 3 papers on SWAP70

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Colocalization confirmed the lead liabilities for MMP-12 (atopic dermatitis, two cohorts) and SWAP70 (rheumatoid arthritis) as on-target effects”
Proteome-Wide Mendelian Randomization Identifies Therapeutic Targets for Ischemic StrokeTranslational stroke research2026doi:10.1007/s12975-026-01509-7
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Department of Finance of Jilin Province
  • Human trial1
  • Humans2

Associations

1

Rheumatoid arthritis

mixedin humans1

1 study
  1. SWAP70 is associated with rheumatoid arthritis in humans (Phenome-wide safety screening and colocalization).

    “Colocalization confirmed the lead liabilities for MMP-12 (atopic dermatitis, two cohorts) and SWAP70 (rheumatoid arthritis) as on-target effects”

    HumansPhenome-wide safety screening and colocalization

    Two blood proteins linked to small-vessel stroke risk

    Translational stroke research

More on Rheumatoid arthritis

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months
Translational Stroke Research

Two blood proteins linked to small-vessel stroke risk

Higher levels of blood proteins SPATA20 and KDELC2 were linked to higher and lower small-vessel stroke odds, respectively (odds ratios 1.47 and 0.82).Higher levels of blood proteins SPATA20 and KDELC2 were linked to higher and lower small-vessel stroke odds, respectively (odds ratios 1.47 and 0.82).

Mendelian randomizationMechanisms